Literature DB >> 8401149

Effect of a single exposure to hyperbaric oxygen on blood mononuclear cells in human subjects.

N Bitterman1, H Bitterman, A Kinarty, Y Melamed, N Lahat.   

Abstract

We studied the effect of a single exposure to a therapeutic profile of hyperbaric oxygen on blood mononuclear cell subset. Twenty healthy volunteers were exposed to 0.28 MPa for 90 min. Thirteen breathed pure oxygen and seven were control subjects exposed to compressed air at the same pressure. Venous blood samples were drawn before HBO exposure, immediately on exit from the chamber, and 24 h later. Immediately after the exposure, a significant increase was observed in the percentage and absolute number of CD8 (suppressor/cytotoxic) T cells, with a concomitant decrease in the CD4 (helper/inducer) T cells. These changes resulted in a decreased CD4:CD8 ratio. A rise was also observed in the number of HLA-DR antigen-bearing cells, with a transient increase in monocytes. There was no change in the total count and percentage of T cells (CD3), B cells, and NK cells. Twenty-four hours after HBO exposure there was a partial reversal of the decrease in the mean CD4:CD8 ratio, but it was still significantly lower than preexposure values. The fast reversibility of the change in the CD4:CD8 ratio suggests specific HBO-induced shifts and sequestration of T-cell subpopulations.

Entities:  

Mesh:

Year:  1993        PMID: 8401149

Source DB:  PubMed          Journal:  Undersea Hyperb Med        ISSN: 1066-2936            Impact factor:   0.698


  7 in total

1.  Modification of in vivo and in vitro TNF-alpha, IL-1, and IL-6 secretion by circulating monocytes during hyperbaric oxygen treatment in patients with perianal Crohn's disease.

Authors:  G Weisz; A Lavy; Y Adir; Y Melamed; D Rubin; S Eidelman; S Pollack
Journal:  J Clin Immunol       Date:  1997-03       Impact factor: 8.317

Review 2.  Hyperbaric oxygen therapy for healthy aging: From mechanisms to therapeutics.

Authors:  Qiaoyu Fu; Ran Duan; Yu Sun; Qingfeng Li
Journal:  Redox Biol       Date:  2022-05-27       Impact factor: 10.787

3.  Hyperbaric oxygen inhibits stimulus-induced proinflammatory cytokine synthesis by human blood-derived monocyte-macrophages.

Authors:  R M Benson; L M Minter; B A Osborne; E V Granowitz
Journal:  Clin Exp Immunol       Date:  2003-10       Impact factor: 4.330

4.  Exposure to hyperbaric oxygen induces tumour necrosis factor-alpha (TNF-alpha) secretion from rat macrophages.

Authors:  N Lahat; H Bitterman; N Yaniv; A Kinarty; N Bitterman
Journal:  Clin Exp Immunol       Date:  1995-12       Impact factor: 4.330

5.  Hyperbaric oxygen therapy as a sole agent is not immunosuppressant in a highly immunogenic mouse model.

Authors:  Adam Gassas; Weixian Min; A Wayne Evans; Susan Carter; George K Sándor; Eyal Grunebaum
Journal:  Bone Marrow Res       Date:  2010-08-03

6.  Hyperbaric oxygen therapy can diminish fibromyalgia syndrome--prospective clinical trial.

Authors:  Shai Efrati; Haim Golan; Yair Bechor; Yifat Faran; Shir Daphna-Tekoah; Gal Sekler; Gregori Fishlev; Jacob N Ablin; Jacob Bergan; Olga Volkov; Mony Friedman; Eshel Ben-Jacob; Dan Buskila
Journal:  PLoS One       Date:  2015-05-26       Impact factor: 3.240

7.  Laparoscopic Nissen fundoplication: The effects of high-concentration supplemental perioperative oxygen on the inflammatory and immune response: A randomised controlled trial.

Authors:  Mario Schietroma; Sara Colozzi; Beatrice Pessia; Francesco Carlei; Marino Di Furia; Gianfranco Amicucci
Journal:  J Minim Access Surg       Date:  2018 Jul-Sep       Impact factor: 1.407

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.